Lupin acquires Rubamin Lab
Lupin acquires Rubamin Lab >Lupin acquired Rubamin Laboratories (RLL), a company belonging to Rubamin Stable. RLL is engaged in manufacture of advanced intermediates for active pharmaceutical ingresdients (APIs) under contract research and manufacturing (CRAMS) model. The company over a decade gained experience in manufacturing advanced intermediates for APIs. Today, it has capabilities to participate in the value chain from drug development to commercial production of advanced intermediate
&n bsp; The company repo>rted phenomenal jump in net profit for the quarter ended June 2007. During the quarter, the company reported 54.75% rise in profit to Rs 783.80 million from Rs 506.50 million in the corresponding quarter, last year.
Net sales for the quarter rose 28.34% to Rs 6,017.50 million, compared with the corresponding quarter, a year ago.
Shares of the company were last trading up Rs 0.05, or 0.01%, at Rs 580.05. The total volume of shares traded was 7,906 at the BSE.(11.04 a.m, Thursday)
